A substantial number of retracted randomized clinical trials can be linked to a small group of scientists, results of a retrospective cohort study showed.
Six “super-retractors” have coauthored more than 20% of retracted randomized clinical trials. Additionally, a group of top-cited scientists in their respective fields who have at least 10 retractions have coauthored 25% of retracted randomized clinical trials.
Altered or fabricated data from these sources have lasted significantly longer in the literature than retracted trials that did not come from these sources.
“The literature is much more

Click here to read the Cover Story, “Specialists strategize on how to address vision issues in children with Down syndrome.”
A recent study led by investigators at Massachusetts General Hospital evaluated the societal supports available to patients with Down syndrome in 50 countries.
Multiple life domains were analyzed, including community inclusion, education, health care, independence, policy and law. The United States had an overall ranking of 13th and ranked 17th for health care services. The top-scoring countries overall were the United Kingdom, Canada, Italy, Netherlands and Spain, which,

Related posts:

1. GenSight Biologics Announces Annual General Meeting to Take Place on May 19, 2026
2. GenSight Biologics Reports Cash Position as of December 31, 2025, and Provides Business Updates
3. GenSight Biologics Reports Cash Position as of September 30, 2025

Children with Down syndrome are naturally predisposed to a variety of ophthalmic disorders, some with a significant impact on vision.
The National Down Syndrome Society reports a 60% to 80% prevalence of eye problems in this population, from less severe abnormalities such as nasolacrimal duct obstruction, slanting palpebral fissures and epicanthal folds to vision-threatening diagnoses such as high refractive errors, optic nerve anomalies, keratoconus and cataract.
High-sensitivity vision screening programs, a multidisciplinary approach and specialized, consistent eye care from birth are crucial

Related posts:

1. Y.ora Vision Launches Following Licensing Agreement Between SERI and Eyexora Global to Advance Minimally Invasive Glaucoma Surgery
2. ‘Burgeoning’ commercial spaceflight industry has implications for physicians
3. The Institute of Clinical Research Launches New Company Membership Scheme to Support Clinical Research Professionals

Related posts:

1. Quay Partners With Klarna to Make Eyewear More Accessible With Flexible Payments
2. Affirm and New Look Vision Group partner to offer flexible payment options across leading eyewear retailers in Canada
3. FGX International Announces Licensing Agreement with Iconic American Brand Wrangler®

Related posts:

1. LambdaVision Books Commercial Space in Low-Earth Orbit with Starlab Space and Voyager Technologies
2. LambdaVision Raises $7M Seed Round to Revolutionize Blindness Treatment Using Space-Based Manufacturing
3. LambdaVision Secures NASA Phase 2 InSPA Award to Advance Manufacturing Efforts in Low-Earth Orbit

The time from outpatient imaging to interpretation by a radiologist more than doubled over the past decade, and most of that increase occurred in 2022 and 2023, which are the most recent data.
An evaluation of more than 2 million Medicare claims between 2014 and 2023 showed that time from CT to interpretation increased over 300%, MRI more than 250% and ultrasound nearly 150%, with disenfranchised communities experiencing longer delays.
“We’ve reached a critical juncture with the workforce,” Eric W. Christensen, PhD, research director at Harvey L. Neiman Health Policy Institute, told Healio.